Speakers
Global Chief Executive, DIA, United States
Barbara Lopez Kunz serves as President and Global Chief Executive of DIA, driving thought leadership and innovation in therapeutic development to improve the health of people worldwide. She previously served as President of Health and Life Sciences at Battelle, one of the world’s...
Read More →
Senior Vice President, Global Head of Product Development Regulatory and Policy, Roche Genentech
Michelle Rohrer, PhD is Global Head of Product Development Regulatory and Policy, as well as the ad interim Global Head of Medical Affairs for Roche Genentech. Michelle has worked at the company for 27 years, starting as a post-doctoral fellow. She has worked as a clinical scientist...
Read More →
Writer, Speaker, Consultant, maryelizabethwilliams.net
Mary Elizabeth Williams is a journalist and author. In 2011, facing metastatic melanoma, she became one of the first people in the world in an innovative immunotherapy clinical trial -- and twelve weeks later showed a complete response. She chronicled her experience in the nonfiction...
Read More →
Chief Medical Officer, ObsEva SA
Elizabeth Garner, MD, MPH completed her medical training at Harvard Medical School and Harvard School of Public Health.
Director, National Center for Advancing Translational Sciences, National Institutes of Health (NIH)
Christopher P. Austin has served as director of the NCATS since 2012. Prior to this role, he was NCATS’ scientific director, focusing on translating basic science discoveries into new treatments and technologies to improve the efficiency of therapeutic/diagnostic development. He...
Read More →
Chief Executive Officer, TransCelerate BioPharma Inc., United States
Dalvir Gill has more than 30 years of drug development & leadership experience. Prior to his appointment as CEO of TransCelerate, he was the President of a major international CRO. Dr. Gill earned his BSc from the University of Hertfordshire and his PhD from the Royal Free Hospital...
Read More →
Executive Vice President, Chief Development Officer, Pfizer Inc
Chief Development Officer and Executive Vice President for Pfizer. Rod leads the Global Product Development organization and is responsible for the clinical development of Pfizer’s pipeline of innovative medicines, as well as regulatory affairs in support of Pfizer’s R&D portfolio...
Read More →
Vice President, Global Health Technologies, RTI International
Doris Rouse, PhD, manages the coordination of diverse disciplines to address major global health needs. Dr. Rouse’s research interests include development of new drugs and drug therapies to combat antibiotic resistance and antimicrobial resistant strains of bacteria. She leads a...
Read More →
Monday June 15, 2020 8:00am - 10:00am EDT
TBD
Virtual Event Horsham, PA 19044